Edesa Biotech EDSA
NASDAQ EDSA
$4.21 +0.65 (+18.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Edesa Biotech (EDSA) Debt Ratio (2021 - 2022)

Updated

Edesa Biotech's Debt Ratio came in at 0.00 for fiscal Q4 2022 (quarter ended Sep 30, 2022), up 16.5% from 0.00 a year earlier.

Analysis

Edesa Biotech (EDSA) Debt Ratio (2021 - 2022) Analysis & Trends

  • Going back by fiscal year, Debt Ratio was 0.00 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Edesa Biotech 34.29 Mn 34.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 0.00
Sep 30, 2021 0.00
API Access

Edesa Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=EDSA&period=max&api_key=YOUR_API_KEY